Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tailored anticoagulant treatment after a first venous thromboembolism: protocol of the Leiden Thrombosis Recurrence Risk Prevention (L-TRRiP) study - cohort-based randomised controlled trial.
Burggraaf-van Delft JLI, van Rein N, Bemelmans RHH, van den Berg JK, Bruggeman CY, Cloos-van Balen M, Coppens M, Eefting M, Ende-Verhaar Y, van Es N, van Guldener C, de Jong WK, Kleijwegt F, Koster T, Kroon C, Kuipers S, Leentjens J, Luijten D, Mairuhu ATA, Meijer K, van de Ree MA, Roos R, Schrover I, Swart-Heikens J, van der Velden AWG, van den Akker-van Marle EM, le Cessie S, Geersing GJ, Middeldorp S, Huisman MV, Klok FA, Cannegieter SC; L-TRRiP investigators. Burggraaf-van Delft JLI, et al. Among authors: luijten d. BMJ Open. 2024 Mar 23;14(3):e078676. doi: 10.1136/bmjopen-2023-078676. BMJ Open. 2024. PMID: 38521524 Free PMC article.
Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: an updated systematic review and meta-analysis.
Luijten D, Talerico R, Barco S, Cannegieter SC, Delcroix M, Ende-Verhaar YM, Huisman MV, Konstantinidis S, Mairuhu ATA, van Mens TE, Ninaber M, Pruszczyk P, Vonk Noordegraaf A, Klok FA. Luijten D, et al. Eur Respir J. 2023 Jul 7;62(1):2300449. doi: 10.1183/13993003.00449-2023. Print 2023 Jul. Eur Respir J. 2023. PMID: 37321620 No abstract available.
Response to letter to the editor: "Clinical controversies in the management of acute pulmonary embolism: evaluation of four important but controversial aspects of acute pulmonary embolism management that are still subject of debate and research".
Luijten D, Klok FA, van Mens TE, Huisman MV. Luijten D, et al. Expert Rev Respir Med. 2023 Jan-Jun;17(6):427-428. doi: 10.1080/17476348.2023.2215015. Epub 2023 May 19. Expert Rev Respir Med. 2023. PMID: 37191014 No abstract available.
A text-mining approach to study the real-world effectiveness and potentially fatal immune-related adverse events of PD-1 and PD-L1 inhibitors in older patients with stage III/IV non-small cell lung cancer.
Abedian Kalkhoran H, Zwaveling J, Storm BN, van Laar SA, Portielje JE, Codrington H, Luijten D, Brocken P, Smit EF, Visser LE. Abedian Kalkhoran H, et al. Among authors: luijten d. BMC Cancer. 2023 Mar 14;23(1):247. doi: 10.1186/s12885-023-10701-z. BMC Cancer. 2023. PMID: 36918817 Free PMC article.
Diagnostic efficacy of ECG-derived ventricular gradient for the detection of chronic thromboembolic pulmonary hypertension in patients with acute pulmonary embolism.
Luijten D, Meijer FMM, Boon GJAM, Ende-Verhaar YM, Bavalia R, El Bouazzaoui LH, Delcroix M, Huisman MV, Mairuhu ATA, Middeldorp S, Pruszcyk P, Ruigrok D, Verhamme P, Vonk Noordegraaf A, Vriend JWJ, Vliegen HW, Klok FA. Luijten D, et al. J Electrocardiol. 2022 Sep-Oct;74:94-100. doi: 10.1016/j.jelectrocard.2022.08.007. Epub 2022 Aug 27. J Electrocardiol. 2022. PMID: 36057190 Free article.
Post Pulmonary Embolism Syndrome.
Luijten D, de Jong CMM, Klok FA. Luijten D, et al. Arch Bronconeumol. 2022 Jul;58(7):533-535. doi: 10.1016/j.arbres.2021.09.008. Epub 2021 Oct 4. Arch Bronconeumol. 2022. PMID: 35312578 English, Spanish. No abstract available.